A start-up company formed by radiologists from Case Western Reserve University in Cleveland hopes to develop a commercial product based on work they have conducted in using MRI to detect and treat atherosclerotic plaque in the coronary arteries. The company, Interventional Imaging Inc. (I3), has been formed by Drs. Jonathan Lewin and Jeffrey Duerk, and the firm has received a technology license from Case Western to pursue the technology.
Lewin and Duerk developed the technology over four years using $2.5 million in external funding. It involves the use of small MRI-compatible catheters to obtain high-resolution images of the coronary arteries and to treat vulnerable atherosclerotic plaques, or plaques that have a high risk of rupturing and causing heart attack or stroke. I3 hopes the initial application of the technology will be to identify vulnerable plaque.
By AuntMinnie.com staff writersJune 10, 2003
Copyright © 2003 AuntMinnie.com
